Key facts
| Price (PPV) | 12,023 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | fingolimod |
| Class | Immunosuppressants |
| ATC code | L04AE01 |
| Manufacturer | NOVARTIS PHARMA MAROC |
| Presentation | Boite de 28 |
| Nature | Médicament |
| Hospital price | 11,795 MAD |
| Data collected on | 9/8/2026 |
Indications
Gilenya est indiqué dans le traitement des adultes, adolescents et enfants à partir de 10 ans atteints de sclérose en plaques (SEP) récurrente-rémittente (évoluant par poussées et rémissions) pour réduire la fréquence des poussées et ralentir la progression du handicap. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About Gilenya 0.5 mg
Gilenya 0.5 mg belongs to the immunosuppressants therapeutic class. In Morocco, this drug is marketed by NOVARTIS PHARMA MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Gilenya 0.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Gilenya 0.5 mg
Answers to common questions from Moroccan patients about this drug.